Asymmetric Upper Limb Dysfunction Demonstrated at the Bedside: A Phenomenology Video
Movement Disorders Clinical Practice, EarlyView.
Gero Lueg +4 more
wiley +1 more source
Local Field Aperiodic Spectral Power Modulated by Deep Brain Stimulation in Parkinson's Disease
Movement Disorders, EarlyView.Abstract Background Aperiodic spectral broadband power has been described recently as reflecting Parkinson's disease (PD) severity. It has therefore become an increasing focus of research interest in the context of the new adaptive deep brain stimulation (DBS) approach.
Martin Lamoš +6 more
wiley +1 more source
The effect of levodopa on speech graphs in non-demented patients with multiple system atrophy and Parkinson's disease. [PDF]
Front NeurolLiu J, Zhao Y, Ma J, Zhang G.
europepmc +1 more source
Early Cervical and Orofacial Variable Dystonia in Levodopa‐Naïve PRKN Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.
Amy Gallagher +6 more
wiley +1 more source
Movement Disorders, EarlyView.Abstract Background Long‐term exposure to air pollution has been linked to Parkinson's disease (PD) incidence, yet evidence is mixed, partly because of challenges with PD diagnosis and definition. We examined this association in a nationwide administrative cohort.
Thomas Cole‐Hunter +14 more
wiley +1 more source
Additive Manufacturing of Shape-Changing Printlets via Powder-Based Extrusion 3D Printing of Natural Cellulose and Polyvinyl Alcohol. [PDF]
Polymers (Basel)Dokhom K +7 more
europepmc +1 more source
Levodopa intolerance as a potential clinical red flag for neuronal intranuclear inclusion disease (NIID) in atypical parkinsonism: a case report. [PDF]
BMC NeurolZang P, Liu Y, Hao Y.
europepmc +1 more source
Missense Variants in the A Isoform of FGF13 as a Novel Cause of Paroxysmal Dyskinesia
Movement Disorders, EarlyView.Abstract Background Pathogenic variants within the unique N‐terminal inactivation particle of FGF13 isoform A (FGF13A) have so far been associated only with an X‐linked dominant epileptic encephalopathy (DEE). Objective The aim was to expand the clinical and molecular spectrum of FGF13A‐related disorder.
Cyril Mignot +22 more
wiley +1 more source
When the Scale Drops: Pathways to Weight Loss in Parkinson's Disease and Future Directions
Movement Disorders, EarlyView.Abstract Although Parkinson's disease (PD) is classically defined by its motor features, non‐motor symptoms exert a substantial and often under‐recognized influence on disease trajectory. Among these, weight loss has long been observed in PD and other neurodegenerative disorders, yet the mechanisms remain incompletely understood.
Ellie D. Gabriel +6 more
wiley +1 more source